NRIX SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0000315066-26-002803
NRIX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 5, 2026. A report the company filed with the SEC (the US market regulator).
Summary of the filing
An institutional holder filed an amended Schedule 13G regarding its ownership position in Nurix Therapeutics, Inc. The filing indicates a change in the holder's passive ownership stake.
Key details
✦ Ask GOAX AI about this filing — what it means for NRIX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NRIX?
Click hereFrequently asked questions
What did NRIX file with the SEC on Nov 5, 2026?
NRIX filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G regarding its ownership position in Nurix Therapeutics, Inc. The filing indicates a change in the holder's passive ownership stake.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other NRIX SEC filings
- 8-K · Contract lossNov 3, 2026
- 8-K · SEC filingOct 13, 2026
- 10-Q · SEC filingOct 13, 2026
- 10-Q · SEC filingJul 9, 2026
- 8-K · SEC filingJul 9, 2026
- 144 · Insider sale plannedJul 2, 2026
- 144 · Insider sale plannedJun 25, 2026
- 144 · Insider sale plannedJun 25, 2026
- 8-K · Fda approvalJun 11, 2026
- 8-K · Material agreementJun 8, 2026
Get alerts when NRIX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days